Am J Transplant, Volume 18, Suppl 3 Archives - Page 141 of 211 - ATC Abstracts

2018 American Transplant Congress
Organ Transplant Abuse in China (1): Scale
G. Yin,¹ D. Li,¹ M. Li,¹ M. Fu.²
¹China Organ Harvest Research Center, Middletown, NY; ²MD Anderson Cancer Center, University of Texas, Houston, TX.
Background and PurposeIn 2006, allegations emerged that the People's Republic of China has been harvesting organs from prisoners of conscience in extrajudicial killings on a…
2018 American Transplant Congress
Perceptions, Motivations, and Concerns about Living Organ Donation among People Living with HIV
S. Rasmussen, M. Henderson, J. Bollinger, S. Seaman, C. Durand, D. Segev, J. Sugarman.
JHU, Baltimore.
Background: The HIV Organ Policy Equity (HOPE) Act permits persons living with HIV (PLWH) to donate organs within research protocols. Motivations and concerns related to…
2018 American Transplant Congress
Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation: A Single Institute Experience with Focus on Epstein-Barr Virus Status
P. Zhang,¹ R. King,¹ K. Ristow,² L. Cornell,¹ F. Cosio,³ T. Habermann,² M. Alexander.¹
¹Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; ²Divsion of Hematology and Oncology, Mayo Clinic, Rochester, MN; ³Divsion of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Background: Comparing to other types of solid organ transplant, the Post-Transplant Lymphopro- liferative Disorder (PTLD) in kidney transplant recipients (KTRs) is relatively rare. Due to…
2018 American Transplant Congress
The Chauvet Workgroup: From Inception to the Future
H. Amer,¹ S. Jowsey-Gregoire,¹ M. Kumnig,² E. Moreno,³ W. Dean,⁴ C. Brown,⁵ S. Jarvholm,⁶ K. Coffman,⁷ P. Petruzzo,⁸ E. Morelon.⁸
¹Mayo Clinic, Rochester, MN; ²University of Innsbruck, Innsbruck, Austria; ³UCLA, Los Angeles, CA; ⁴US Department of Defense, Fort Detrick, MD; ⁵University of Pittsburgh, Pittsburgh, PA; ⁶University of Gothenburg, Gothenburg, Sweden; ⁷Cleveland Clinic, Cleveland, OH; ⁸University of Lyon, Lyon, France.
From the first hand transplant that ushered in the era of reconstructive transplantation, it was apparent that the psychosocial background of the patient and the…
2018 American Transplant Congress
Shared Genetic Ancestry as a Predictor of Medium Term Renal Transplant Outcome in Deceased Donor Transplants
C. Stapleton,¹ On behalf of the UK and Ireland Renal Transplant Consortium, P. Conlon,² G. Cavalleri.¹
¹Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland; ²Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
Sibling transplant pairs have better transplant outcomes than unrelated donor recipient (DR) pairs indicating that shared genetic ancestry between donors and recipients can aid in…
2018 American Transplant Congress
Sub-Clinical Acute Rejection (subAR) Detected by Both Surveillance Biopsy (SBx) and a Peripheral Blood Molecular Biomarker Correlates with De Novo Donor Specific Antibody (dnDSA) Following Kidney Transplant (KT)
R. Heilman,¹ J. Friedewald,² K. Kurian,⁵ T. Whisemant,⁵ E. Poggio,³ C. Marsh,⁵ P. Baliga,⁷ N. Bridges,⁴ J. Odim,⁴ M. Brown,⁴ D. Ikle,³ B. Armstrong,³ L. Zhao,² D. Salomon,⁵ M. Abecassis.²
¹Mayo Clinic, Phoenix; ²Northwestern University, Chicago; ³Rho Federal Systems, Chapel Hill; ⁴National Institute of Allergy and Infectious Disease, Bethesda; ⁵Scripps Health, La Jolla; ⁶Cleveland Clinic, Cleveland; ⁷Medical University of South Carolina, Charleston.
AIMWe investigated the correlation between subAR diagnosed by SBx or by a newly-defined biomarker, and the development of dnDSA.METHODS307 KT patients enrolled into a multi-center…
2018 American Transplant Congress
Donor Plasma Mitochondrial DNA Predicts Post-Transplant Renal Allograft Outcomes
F. Han,¹ S. Wan,² N. Chen,² L. Zheng,³ N. Zhang,⁴ Q. Sun,¹ H. Li,¹ Z. Huang,¹ L. Hong,¹ Q. Sun.¹
¹Kidney Transplantation, Sun Yat-sen University, Guangzhou, China; ²Laboratory of Cancer Biomarkers and Liquid Biopsy, Henan University, Henan, China; ³Department of Medical Statistics and Epidemiology, Sun Yat-sen University, Guangzhou, China; ⁴Department of Pathology, Sun Yat-sen University, Sun Yat-sen, China.
The lack of an accurate biomarker makes it difficult to determine whether an organ is acceptable for transplantation. Mitochondrial DNA (mtDNA) correlates with tissue damage…
2018 American Transplant Congress
Outcomes after Kidney Transplantation in Patients with AL Amyloid Following Autologous Stem Cell Transplantation
V. Gutgarts,^1,2 I. Jaffer Sathick,² C. Rosenbaum,³ T. Muthukumar,¹ H. Hassoun,⁴ C. Flombaum,² H. Landau.⁴
¹Nephrology, Weill Cornell, NY; ²Renal Medicine, Memorial Sloan Kettering, NY; ³Hematology, Weill Cornell, NY; ⁴Hematology, Memorial Sloan Kettering, NY.
BackgroundAL amyloidosis results in kidney failure in about 15-30% of patients and is considered a relative contraindication for kidney transplantation. There is limited data on…
2018 American Transplant Congress
Improved Value with Individualized Antithymocyte Globulin Dosing Protocol in Renal Transplant
J. Dann, W. Ally, M. Bradley, J. Geyston, A. Agarwal.
University of Virginia Healthsystem, Charlottesville, VA.
Medication costs represent one of the largest costs associated with transplantation. With growing pressure to reduce health care costs while maintaining excellent outcomes, this study…
2018 American Transplant Congress
Long Term Outcomes of a Steroid Free, Low Dose Tacrolimus with Everolimus Regimen in Kidney Transplant
Y. Kassis,¹ S. Park,¹ A. Shetty,¹ J. Leventhal,¹ V. Mas,² L. Gallon.¹
¹Comprehensive Transplant Center, Northwestern University, Chicago, IL; ²Department of Surgery, University of Virginia, Charlottesville, VA.
Tacrolimus (Tac) is the most effective immunosuppressive agent to prevent acute allograft rejection. However, long-term transplant (Tx) outcomes are limited, at least in part, by…